Longboard Pharmaceuticals, Inc entered into a Non-Voting Common Stock Purchase Agreement and issued 2,850,000 shares of its non-voting common stock to the Investor at a purchase price of $21 per share, for aggregate gross proceeds of $59,850,000 on March 26, 2024. The transaction included participation from returning investor, Farallon Capital Management, L.L.C.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.72 USD | +2.44% | +13.07% | +227.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+227.03% | 767M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- LBPH Stock
- News Longboard Pharmaceuticals, Inc.
- Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding